Endometriosis is a gynecological condition where endometrial tissue grows outside the uterus.
Symptoms of
endometriosis can include painful periods, pelvic pain, and infertility.
A laparoscopic surgery is often performed to diagnose and treat
endometriosis by removing the misplaced tissue.
Endometriosis affects approximately 1 in 10 women worldwide, making it a common reproductive health issue.
Hormonal therapies are sometimes prescribed to help manage pain and slow down the growth of endometrial tissue.
Women with
endometriosis may experience chronic pelvic pain, which can significantly impact their quality of life.
Endometriosis can lead to scarring (adhesions) within the pelvic cavity, complicating fertility and increasing the risk of ectopic pregnancy.
Support groups and online communities provide emotional support for those living with
endometriosis and its associated challenges.
Early diagnosis and management of
endometriosis are crucial for reducing long-term complications and improving treatment outcomes.
Research continues to explore new treatments, such as immunotherapy, to target and potentially cure this debilitating disease.
子宫内膜异位症是一种妇科疾病，子宫外的内膜组织生长。
子宫内膜异位症的症状可能包括痛经、下腹痛和不孕。
通常通过腹腔镜手术来诊断并移除异常组织以治疗子宫内膜异位症。
在全球范围内，大约每10名女性中有1人受到子宫内膜异位症的影响，这是一个常见的生殖健康问题。
激素疗法有时被用来帮助控制疼痛并减缓内膜组织的增长。
子宫内膜异位症患者可能会经历长期的盆腔疼痛，这会显著影响她们的生活质量。
子宫内膜异位症可能导致盆腔内的疤痕（粘连），影响生育并增加异位妊娠的风险。
提供情感支持的互助小组和在线社区为患有子宫内膜异位症及其相关挑战的人们提供帮助。
对子宫内膜异位症的早期诊断和管理对于减少长期并发症和改善治疗效果至关重要。
研究仍在探索新的治疗方法，如免疫疗法，以针对并可能治愈这种令人痛苦的疾病。
He said China's inclusiveness and economic vitality have boosted the company's confidence in the promising market, and pointed out that since its spinoff, Organon has sealed eight global business deals, with a focus on high-incidence women-specific conditions such as endometriosis and polycystic ovary syndrome.
他说，中国的包容性和经济活力增强了该公司对这个充满希望的市场的信心，并指出，自分拆以来，Organon已经达成了八项全球业务协议，重点关注子宫内膜异位症和多囊卵巢综合征等高发女性特异性疾病。
"We have invested deeply in the research and development of preterm labor, postpartum hemorrhage, endometriosis and many other disease areas to change the situation for women.
“我们在早产、产后出血、子宫内膜异位症和许多其他疾病领域的研发上投入了大量资金，以改变女性的状况。
At Bayer, the promise of P2X3 antagonists was first identified for endometriosis.
Endometriosis is a clinical condition affecting approximately 10 percent of women in reproductive age, many of whom experience severe chronic pain with debilitating effects on their professional, personal and social lives.
未经许可，严禁转发。QQ交流群：688169419